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HEPATITIS C VIRUS SEROPREVALENCE AND RISK FACTORS AMONG PATIENTS
WITH HIV INFECTION
Maria Cássia J. MENDES-CORRÊA(1), Antonio Alci BARONE(2) & Cristina GUASTINI(3)
SUMMARY
The objective of this study was to evaluate the prevalence and risk factors associated with HCV infection in a group of HIV
seropositive patients. We analyzed the medical records of 1,457 patients. All patients were tested for HCV infection by third generation
ELISA. Whenever possible, a sample of the positive patients was also tested for HCV by PCR. HCV positive patients were analyzed
according to their risk factors for both infections. The prevalence of anti-HCV positive patients was 17.7% (258 patients). Eighty-two
(82) of these patients were also tested by PCR and 81 were positive for HCV virus (98%). One hundred fifty-one (58.5%) were
intravenous drug users (IDU); 42 (16.3%) were sexual partners of HIV patients; 23 (8.9%) were homosexual males; 12 (4.7%) had
received blood transfusion; 61 (17.5%) had promiscuous sexual habits; 14 (5.4%) denied any risk factor; 12 (4.7%) were sexual
partners of IDU. Two hundred four patients mentioned only one risk factor. Among them, 28 (10.9%) were sexual partners of HIV-
positive patients. Although intravenous drug use was the most important risk factor for co-infection, sexual transmission seemed to
contribute to the high HCV seroprevalence in this group of patients.
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INTRODUCTION
Hepatitis C virus (HCV) and HIV share the same parenteral, sexual
and vertical routes of transmission. Hepatitis C is primarily spread by
parenteral or blood borne exposures, such as transfusion of blood products
or intravenous drug use. Sexual transmission, however, can occur,
occupational exposures have been reported, and perinatal transmission
has been documented. This common epidemiology explains the high
frequency of combined infections by this virus and HIV.
Hepatitis C virus (HCV) infection occurs throughout Brazil and until
the recent introduction of serological tests for HCV, the prevalence of
this infection was not known. The use of screening assays for HCV in
blood banks has uncovered a large population of asymptomatic carriers.
Among blood donors the prevalence of antibody to HCV (anti-HCV)
varies between 0.84% to 3.4% in different parts of Brazil. In São Paulo,
where this study was conducted, the prevalence of antibody to HCV in
blood donors is 0.84%2 .
Populational studies on the prevalence of virus C infection are not
common in Brazil. Three different studies have shown it to vary between
0 to 3%6,10,16 . Patients co-infected with both HIV and HCV have a higher
risk of progression to chronic liver disease than those infected with HCV
alone15,17,19. However, little is known about the effect of co-infection on
the progression of HIV disease4,14,21.
Limited information is available about hepatitis C virus infection in
patients with HIV infection in Brazil11,12. This study was designed as
part of a protocol of treatment of patients with chronic hepatitis C and
HIV infections in our department. The objective was to evaluate: 1) the
prevalence of HCV, 2) the risk factors and the association among them,
in a group of HIV/HCV patients, followed at our institution from January
to December, 1996.
PATIENTS AND METHODS
This study was conducted at an AIDS Outpatient Clinic, which
belongs to the Department of Infectious Diseases, São Paulo University
School of Medicine.
From January 1996 through December 1996, 1457 patients (1009
male, 448 female), were attended at the AIDS Outpatient Clinic and
were tested for HCV infection.
Laboratory data was extracted from a data base used in the follow
up of these patients.
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Tests for anti-HCV were done by ELISA (Abbott HCV EIA second
generation and third generation) according to the manufacturer’s
instructions. HCV RNA was investigated by the “nested” polymerase
chain reaction (PCR) using two sets of oligonucleotide primers derived
from 5’ non-coding region. All serologic studies were performed at the
Central Laboratory of Hospital das Clinicas.
PCR tests were performed at the Laboratório de Investigação Médica
em Hepatites da Faculdade de Medicina da Universidade de São Paulo.
Medical records from 258 patients, co-infected by HIV and HCV were
reviewed.
Demographic data, risk behaviors and clinical information were
obtained from medical records and the data base used in follow up of
these patients. Ninety five out of these 258 patients were also
interviewed by one of the authors, comprising questions involving
identification, demographic characteristics, AIDS/hepatitis knowledge,
AIDS treatment, risk factors (use of intravenous illegal drugs, blood
transfusion, sexual behavior, possible sexual contact with someone
seropositive for either HIV or HCV, use of inhaled drugs, body piercing,
tattooing). When answering the questions, the patients were asked about
their sexual habits and could choose between the following categories:
heterosexual, bisexual, male or female homosexual. All patients were
also asked about the frequency of their sexual practice. Sexual
promiscuity was defined as more than two different sexual partners
during the last six months.
Statistical analysis of risk factors was performed using correspondence
analysis technique8. This is an exploratory multivariate analysis that
represents each level of categorical variables in a two-dimensional plan.
The association between two factors may be interpreted by the size of the
angles formed between vectors from the origin to each point. The smaller
the angle between two levels of different factors, the stronger is the
association between them.
RESULTS
The estimated prevalence of anti-HCV antibodies among the 1,457
patients tested for HCV was 17.7% with 95% confidence interval of
[15.8%; 19.8%]. Among the 258 anti-HCV positive patients, 82 were
also tested by HCV-RNA by “nested” polymerase chain reaction
(“nested” PCR) and 81 were positive for HCV virus (98%).
Two hundred and two (82.2%) anti-HCV positive patients were male
and age varied from 20 to 61 years, with mean of 34.08 and standard-
deviation of 7.19 years.
The frequency of each risk factor in these patients can be seen on
Table 1.
One single factor was mentioned by 204 (79.1%) patients; two
combined factors, by 51 (19.8%) patients and three combined factors,
by 3 (1.2%) patients.
Among those patients who mentioned only one risk factor: 106
(41.1%) were intravenous drug users; 29 (11.2%) had more than 2 sexual
partners; 28 (10.9%) were sexual partners of HIV patients (without any
other risk factor for HCV); 14 (5.4%) were homosexual males; 7 (2.7%)
were sexual partners of intravenous drug users; 6 (2.3%) had received
blood transfusion and 14 (5.4%) denied any of the risk factors cited
above. Table 2 shows the associations of risk factors.
Through correspondence analysis it was possible to infer which risk
factors were more associated to each other. Figure 1 shows the vectors
representing the positive status of each risk factor. It may be observed that
the vectors representing the risk factors sexual partner of HIV seropositive
patients and sexual partner of intravenous drug users, have small angles
between them, indicating association between these risk factors.
DISCUSSION
The prevalence of antibodies to HCV in HIV infected patients varies
according to the risk factor for HCV and HIV infection and to the
serological assay used. Among HIV/hemophiliacs the prevalence of anti-
HCV varies between 60% to 95%, and, among HIV/IDU, it may be
around 70%19.
The prevalence of anti-HCV may also be underestimated by
fluctuations or spontaneous disappearance of antibodies to HCV in HIV
seropositive patients. WOOLEY et al.20 found out that 18 out of 52 HIV-
positive patients, negative for anti-HCV, had HCV-RNA in plasma by
polymerase chain reaction test.
Our study has shown that among 1,457 HIV-infected patients, 17.7%
were co-infected by HCV. This seroprevalence is much higher than the
prevalence among blood donors or the seroprevalence obtained through
populational studies in Brazil. Such high seroprevalence is easy to
understand when we analyze the epidemiology of HIV infection in Brazil.
Table 1
Prevalence and 95% confidence interval of each risk factor
Risk Factor N prevalence 95% confidence interval
Intravenous drug users 151 58.5% [52.2 ; 64.6]
Promiscuous sexual habits 61 23.6% [18.6 ; 29.3]
Sexual partners of HIV seropositive patients 42 16.3% [12.0 ; 21.4]
Homosexual males 23 8.9% [ 5.7 ; 13.1]
Received blood transfusion 12 4.7% [ 2.4 ; 8.0]
Sexual partners of intravenous drug users 12 4.7% [ 2.4 ; 8.0]
Denied any of the risk factors listed above 14 5.4% [ 3.0 ; 8.9]
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An evolving pattern in the epidemiology of this infection has become
evident in most countries of the Americas, including Brazil. Substantial
differences in the distribution of cases, according to exposure category,
have been noted in the present decade when compared to the early 1980s.
Initially, the epidemic predominated in the male homosexuals or
bisexuals, hemophiliacs and others who had received blood products.
However, within the past few years, there has been an increase of HIV
among IDUs and heterosexuals18.
The first registered case of HIV infection in an intravenous drug
user in Brazil was in 1982. This category is responsible at present for
about 20% of accumulated AIDS cases in this country7.
In Brazil, the HIV epidemics among cocaine injectors, and more
recently among heroin injectors, are compounded by the association of
crack cocaine use and the practice of unsafe sexual behaviors. HCV
infection is more rapidly acquired after initiation of intravenous drug
use than other viral infections (hepatitis B virus and HIV). Also, rates of
HCV infection among young intravenous drug users are four times higher
than rates of HIV infection. More rapid acquisition of HCV infection
compared with other viral infections among IDUs is likely to be caused
by high prevalence of chronic HCV infection among IDUs, which results
in a greater likelihood of exposure to an HCV infected person3.
Intravenous drug use was the most frequent risk factor involved in
our study, which is in agreement with the epidemiology for HIV infection
observed in Brazil, as exposed above.
It was also very interesting to observe that the second largest risk
factor for HCV acquisition (16.3%) was being a sexual partner of an
HIV seropositive person.
Table 2
Frequency of patients mentioning association among 2 or 3 risk factors
Risk factor 1 Risk factor 2 Risk factor 3 N %#
Intravenous drug users Sexual partners of HIV+ 9 3.5%
Intravenous drug users Homosexual males 5 1.9%
Intravenous drug users Promiscuous sexual habits 26 10.1%
Intravenous drug users Sexual partners of IDU 2 0.8%
Sexual partners of HIV+ Homosexual males 1 0.4%
Sexual partners of HIV+ Sexual partners of IDU 3 1.2%
Sexual partners of HIV+ Received blood transfusion 1 0.4%
Homosexual males Received blood transfusion 1 0.4%
Received blood transfusion Promiscuous sexual habits 3 1.2%
Intravenous drug users Homosexual males Promiscuous sexual habits 2 0.8%
Intravenous drug users Received blood transfusion Promiscuous sexual habits 1 0.4%
#: percentage over 258 patients; pts: patients; IDU: intravenous drug users
Fig. 1 - Correspondence analysis of HIV risk factors. Each vector represents the presence of one risk factor. The categories of absence of each risk factor were not represented in this figure .
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Among the patients who mentioned only one risk factor, 28 out of
204 (10.9%) were sexual partners of HIV-positive patients and denied
any other risk factor for HIV/HCV infection. The proportion of the
different risk factors involved in the groups analyzed was maintained.
Through correspondence analysis it was also possible to infer an
association between the risk factors: sexual partner of HIV seropositive
patients and sexual partner of intravenous drug users. This association
could easily be explained by the fact that these groups may have similar
exposures and are frequently compounded by the same persons.
Sexual transmission of HCV has been a matter of important
controversy in literature. Case-control studies have reported an
association between exposure to a sex contact with a history of hepatitis
or exposure to multiple sex partners and the acquisition of hepatitis C.
In contrast, a low prevalence of HCV infection has been reported by
different studies of long term spouses of patients with chronic HCV
infection. The average prevalence of HCV infection in this situation is
1.5% (range: 0% to 4.4%)3.
Although there are important differences among different studies on
this subject, there are sufficient data to indicate that sexual transmission
of HCV may occur, but that this virus is probably inefficiently spread
through this route.
A more precise way to examine the issue of sexual transmission is to
test the monogamous sexual partners of HCV-infected individuals.
LISSEN et al.9 examined 147 such heterosexual partners, who denied
intravenous drug use or blood transfusion. According to this study the
anti-HCV prevalence in stable heterosexual partners of HCV/HIV index
cases was 2.2 times higher than in stable heterosexual partners of index
cases reactive for anti-HCV only (9.2% vs. 4.1%).
Among partners of hemophilics co-infected with HCV/HIV,
BRETTLER et al. reported an average prevalence of HCV infection of
3%1.
EYSTER et al. also studied female sexual partners of anti-HCV
positive hemophiliacs5. According to this study, female sexual partners
of anti-HCV positive hemophiliacs were found to be at four times greater
risk of acquiring HCV if the hemophiliac was co-infected with HIV.
Our study has shown a significant proportion of HCV/HIV patients
who mentioned, as their only risk factor, the fact of being sexual partners
of HIV-positive patients.
Although we do not know the HCV status of those HIV partners, it
is possible that most of them were probably HCV positive, as well. It
would be interesting to suppose that HIV infection could increase the
chances of sexual HCV transmission.
Some studies have suggested that the level of HCV viremia is higher
in HIV-infected patients when compared to HIV-negative patients19.
Higher HCV replication is suggested by the more frequent vertical
transmission of HCV to newborns from HIV-infected mothers than from
HIV-negative mothers. In HIV-negative mothers the risk of transmission
is clearly related to the level of viremia13.
Eighty-two of our 258 anti-HCV positive patients were tested by
HCV-RNA by “nested” PCR and 81 were positive (98%). This data could
suggest that patients with HIV and HCV are more likely to have active
HCV infections with persistent viremia.
It is possible that sexual transmission of HCV could be enhanced in
HIV-positive patients due to higher HCV viremia and also due to more
active HCV infection with persistent viremia.
RESUMO
Prevalência e fatores de risco da hepatite C em pacientes
infectados pelo vírus da imunodeficiência humana
O objetivo do presente estudo foi avaliar a prevalência e os fatores
de risco associados à infecção pelo vírus da hepatite C (VHC) em um
grupo de pacientes soropositivos para o HIV. Analisamos os prontuários
médicos de 1.457 pacientes. O diagnóstico laboratorial de infecção
pelo VHC foi feito utilizando-se ELISA de terceira geração. Uma parte
dos pacientes soropositivos para VHC foram também submetidos à
realização de PCR. Os pacientes soropositivos para VHC foram
analisados em relação aos fatores de risco para ambas as infecções. A
prevalência de pacientes soropositivos para VHC foi de 17,7% (258
pacientes). 82 desses pacientes foram testados para VHC por PCR e
81 (98%) apresentaram-se com resultado positivo. 151 (58,5%)
referiram uso de drogas endovenosas (UDE), 42 (16,3%) eram parceiros
sexuais de pacientes infectados pelo HIV, 23 (8,9%) eram homossexuais
masculinos, 12 (4,7%) tinham recebido transfusão sanguínea, 61
(17,5%) referiram promiscuidade sexual, 14 (5,4%) negaram qualquer
fator de risco, 12 (4,7%) eram parceiros sexuais de UDE. 204 pacientes
referiram apenas um fator de risco, 51 referiram dois diferentes fatores
de risco e três referiram três diferentes fatores de risco. Entre os
pacientes que referiram apenas um fator de risco, 28 em 204 (10,9%)
eram parceiros sexuais de pacientes infectados pelo HIV. Embora o
uso de drogas endovenosas tenha sido o fator de risco mais importante
na determinação da co-infecção, a transmissão sexual parece ter
contribuído para a alta soroprevalência do VHC nesse grupo de
pacientes.
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